A preliminary report: Frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy

Cancer Journal from Scientific American

Volumn 4, Issue 6, 1998, Pages 385-389

  Hall, Eric J ^a,b   Schiff, Peter B ^b   Hanks, Gerald E ^c   Brenner, David J ^a   Russo, James ^b   Chen, Jing ^b   Sawant, Satin G ^a   Pandita, Tej K ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

A T heterozygotes; Ataxia telangientasia; Genetic predisposition; Late effects; Mutations in ATM gene; Prostate cancer; Radiation therapy and cancer; Radiosensitive subgroup

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CYSTITIS; DISEASE ASSOCIATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SCREENING; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIOSENSITIVITY;

ATAXIA TELANGIECTASIA; DNA PRIMERS; EXONS; HETEROZYGOTE DETECTION; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE;

EID: 0031738103     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Landis SH, Murray T, Bolden S et al. Cancer statistics, 1998. Cancer J Clin 1998;48:6-29.
2. Mettlin C. Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993. Prostate 1997;32:221-226.
3. Gerber RL, Smith AR, Owen J et al. Patterns of care survey results: treatment planning for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1995;33:803-808.
4. Zelefsky MJ, Leibel SA, Kutcher GJ et al. Three-dimensional conformal radiotherapy and dose escalation; where do we stand? Radiat Oncol 1998;8:107-114.
5. Schultheiss TE, Lee WR, Hunt MA et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:3-11.
6. Sedgwick RP, Boder E. Ataxia-telangiectasia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. New York: Elsevier, 1991:347-423.
7. Harnden DG. The nature of ataxia-telangiectasia: problems and perspectives. Int J Radiat Biol 1994;66[suppl]: S13-19.
8. Shiloh Y. Ataxia-telangiectasia: closer to unraveling the mystery. Eur J Hum Genet 1995;3:116-138.
9. Taylor AMR, Harnden DG, Arlett CF et al. Ataxia telangiectasia: a mutation with abnormal radiation sensitivity. Nature 1975;258: 427-429.
10. Houlsworth J, Lavin MF. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia. Nucleic Acids Res 1980;8:3709-3720.
11. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980;77:7315-7317.
12. Paterson MC, MacFarlane SM, Gentner NE et al. Cellular hypersensitivity to chronic gamma-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes. In: Gatti RA, Swift M, eds. Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood. New York: Liss, 1980:73-87.
13. Cornforth MN, Bedford JS. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 1985;227: 1589-1591.
14. Rudolph NS, Nagasawa H, Little J et al. Identification of ataxia telangiectasia heterozygotes by flow cytometric analysis of X-ray damage. Mutat Res 1989;211:9-29.
15. Blocher D, Sigut D, Hannan MA. Fibroblasts from ataxia telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol 1991;60:791-802.
16. Weeks DE, Paterson MC, Lange K et al. Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat Res 1991;128:90-99.
17. Pandita TK, Hitelman WN. Increased initial levels of chromosome damage and heterogenous chromosome repair in ataxia telangiectasia heterozygote cells. Mutat Res 1994;310:1-13.
18. Savitsky K, Bar-Shira A, Gilad S et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995:268: 1749-1753.
19. Savitsky K, Sfez S, Tagle DA et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995;4:2025-2032.
20. Zakian VA. ATM-related genes: what do they tell us about functions of the human gene? Cell 1995;82:685-687.
21. Gilad S, Khosravi R, Shkedy D et al. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 1996;5:433-439.
22. Zentner PG, Pao K, Benson MC et al. Prostate-specific antigen density: a new prognostic indicator for prostate cancer. Int J Radiat Oncol Biol Phys 1993;27:47-58.
23. Ennis RD, Malyszko BK, Rescigno, J et al. Biologic classification as an alternative to anatomic staging for clinically localized prostate cancer: a proposal based on patients treated with external beam radiotherapy. Adult Urol 1998;51:265-270.
24. Schultheiss TE, Hanks GE, Hunt MA et al. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1995;32:643-649.
25. Freyer GA, Palmer DA, Yu Y et al. Neoplastic transformation of mouse C3H 10T1/2 cells after exposure to neutrons does not involve mutation of ras gene as analyzed by SSCP and cycle sequencing. Mutat Res 1996;357:237-244.
26. Orita M, Iwahana H, Kanazawa H et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86: 2766-2770.
27. Vorechovsky I, Rasio D, Luo L et al. The ATM gene and susceptibility to breast cancer analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 1996;56:2726-2732.
28. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996;92:130-134.
29. Chen J, Birkholtz GG, Lindblom P et al. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res 1998; 58:1376-1379.
30. FitzGerald MG, Bean JM, Hegde SR et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 1997;15:307-310.
31. Abadir R, Hakami N. Ataxia telangiectasia with cancer: an indication for reduced radiotherapy and chemotherapy doses. Br J Radiol 1983;56:343-345.
32. Appleby JM, Barber JB, Levine E et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 1997;76:1546-1549.
33. Liu Q, Sommer SS. Restriction endonuclease fingerprinting (REF): a sensitive method for screening mutations in long, contiguous segments of DNA Biotechniques 1995;18:470-477.
34. Wallace RW. DNA on a chip: serving up the genome for diagnostics and research. Mol Med Today 1997;3:384-389.